Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
Add more filters











Publication year range
1.
Poult Sci ; 91(11): 2812-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23091137

ABSTRACT

Production of ducks and geese in certain parts of the world is very important. Mycoplasma diseases cause significant losses to the duck and goose industry. This review summarizes the epidemiological, clinical, and pathomorphological characteristics of mycoplasma diseases of ducks and geese and the involvement of the various mycoplasma species in their pathogenesis. The role of mycoplasma infections in the development of clinical signs, pathological lesions, and mortality of challenged birds is demonstrated in challenge experiments. Transmission of mycoplasma in the ovary and eggs resulting in the reduction of egg production and an increase of embryo mortality has been shown in challenge experiments as well as in field studies. The susceptibility of many mycoplasma isolates of the most important mycoplasma species of duck and goose origin were tested and showed relatively high average minimum inhibitory concentrations of lincomycin, tilosin, oxytetracycline, chlortetracycline, and enrofloxacin but not for tiamulin. The successful treatment of mycoplasma infections with antibiotics in ducks and geese should be selected based on the minimum inhibitory concentration values against the mycoplasmas isolated from the flock.


Subject(s)
Ducks/microbiology , Geese/microbiology , Mycoplasma Infections/veterinary , Mycoplasma/classification , Animals , Anti-Bacterial Agents/therapeutic use , Mycoplasma Infections/drug therapy , Mycoplasma Infections/microbiology
2.
Vet Pathol ; 49(2): 273-83, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21825309

ABSTRACT

Chickens were infected under experimental conditions with Mycoplasma gallisepticum and low pathogenic avian influenza (LPAI) strain A/mallard/Hungary/19616/07 (H3N8). Two groups of chickens were aerosol challenged with M. gallisepticum strain 1226. Seven days later, one of these groups and one mycoplasma-free group was challenged with LPAI H3N8 virus; one group without challenge remained as negative control. Eight days later, the birds were euthanized and examined for gross pathologic and histologic lesions. The body weight was measured, and the presence of antimycoplasma and antiviral antibodies was tested before the mycoplasma challenge, before the virus challenge, and at the end of the study to confirm both infections. Chickens in the mycoplasma-infected group developed antibodies against M. gallisepticum but not against the influenza virus. Chickens of the group infected with the influenza virus became serologically positive only against the virus, while the birds in the coinfected group developed antibodies against both agents. The LPAI H3N8 virus strain did not cause decrease in body weight and clinical signs, and macroscopic pathological lesions were not present in the chickens. The M. gallisepticum infection caused respiratory signs, airsacculitis, and peritonitis characteristic of mycoplasma infection. However, the clinical signs and pathologic lesions and the reduction in weight gain were much more significant in the group challenged with both M. gallisepticum and LPAI H3N8 virus than in the group challenged with M. gallisepticum alone.


Subject(s)
Chickens , Influenza A Virus, H3N8 Subtype/pathogenicity , Influenza in Birds/pathology , Mycoplasma Infections/veterinary , Mycoplasma gallisepticum/pathogenicity , Poultry Diseases/pathology , Animals , Antibodies, Bacterial/biosynthesis , Antibodies, Bacterial/blood , Antibodies, Viral/biosynthesis , Antibodies, Viral/blood , Bronchitis/microbiology , Bronchitis/pathology , Bronchitis/veterinary , Bronchitis/virology , Coinfection , Hungary , Influenza A Virus, H3N8 Subtype/immunology , Influenza in Birds/complications , Motion Sickness/veterinary , Mycoplasma Infections/complications , Mycoplasma Infections/pathology , Mycoplasma gallisepticum/immunology , Pneumonia/microbiology , Pneumonia/pathology , Pneumonia/veterinary , Pneumonia/virology , Poultry Diseases/microbiology , Poultry Diseases/virology , Respiratory Mucosa/pathology , Specific Pathogen-Free Organisms , Trachea/pathology , Tracheitis/microbiology , Tracheitis/pathology , Tracheitis/veterinary , Tracheitis/virology , Virulence , Weight Gain
3.
Acta Microbiol Immunol Hung ; 57(4): 349-76, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21183422

ABSTRACT

Lymphomas are solid tumors consisting of lymphoid cells; they form a heterogeneous group of less or more malignant disorders. A portion of lymphomas develop due to latent herpesvirus infections established in B and/or T-lymphocytes. The basis for latency is a lifelong presence of the circularized covalently linked viral genome within nuclei of carrier lymphocytes. In certain cases, however, the essential event leading to tumor formation is the integration of a portion(s) of viral DNA into the host cell DNA. This leads to rearrangements within the host cell genome on one hand, and, on other hand, to unregulated expression of oncoproteins encoded by the integrated fragment. Our review deals with mechanisms of lymphoma formation regarding to the role of non-structural herpesvirus oncoproteins interfering with the regulation of cell division and/or exerting anti-apoptotic effects. In addition, the authors wish to highlight the common procedures, which allowed isolation and/or identification of lymphoma-associated viruses in cell cultures derived from tumors and/or proliferating lymphatic tissues.


Subject(s)
Gammaherpesvirinae/physiology , Herpesviridae Infections/virology , Lymphoma/virology , Oncogene Proteins, Viral/genetics , Tumor Virus Infections/virology , Virus Latency , Animals , B-Lymphocytes/virology , Cell Division , DNA, Viral/genetics , Gammaherpesvirinae/genetics , Gammaherpesvirinae/isolation & purification , Genome, Viral , Herpesviridae Infections/genetics , Herpesviridae Infections/pathology , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/physiology , Humans , Lymphoma/genetics , Lymphoma/pathology , Oncogene Proteins, Viral/physiology , T-Lymphocytes/virology , Tumor Virus Infections/pathology
4.
Int J Artif Organs ; 27(6): 480-7, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15291078

ABSTRACT

The structural component of Gram- bacteria, endotoxin (ET), induces the release of endogenous mediators of sepsis. Attempts to remove these downstream molecules in vivo, have not improved survival. However, extracorporeal strategies such as continuous renal replacement therapy or therapeutic plasmapheresis have shown benefit. We are presenting an affinity-based extracorporeal technology for the removal of ET from whole blood. The small-scale device contains an adsorbent that removed 75% of ET present in whole blood. This affinity resin displayed good hemocompatibility regarding the coagulation pathway. Minimal platelet, neutrophil and complement activation were observed. There was also no evidence of consumption of coagulation factors or cell loss. In as much as ET participates in both the inflammatory and coagulation abnormalities in sepsis, this method represents an efficient and hemocompatible way to remove ET from whole blood, which, in an extracorporeal setting, may improve the outcome of sepsis.


Subject(s)
Anti-Infective Agents/pharmacology , Endotoxins/blood , Ofloxacin/pharmacology , Adsorption , Blood Coagulation Factors/analysis , Cell Count , Chromatography, Affinity/methods , Complement C3a/analysis , Fibrinogen/analysis , Gram-Negative Bacterial Infections/therapy , Hemostasis , Humans , Leukocyte Elastase/blood , Ligands , Monocytes/metabolism , Sepharose , Shock, Septic/therapy , Transforming Growth Factor beta/blood , Tumor Necrosis Factor-alpha/metabolism
5.
Neurochem Res ; 25(6): 801-7, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10943998

ABSTRACT

Cerebral taurine acts as neurotransmitter, as neuromodulator, or as osmoregulator. To investigate its release mechanisms in vivo, we combined the microdialysis technique with a variety of experimental paradigms. Taurine release was stimulated by either NMDA, NO or a hypotonic solution locally with or without the addition of the NMDA antagonists APV or Ketamine, or the NO synthase inhibitor L-NAME. Alternatively, the neuroprotective drug lubeluzole was applied i.v. NMDA, NO or the hypotonic solution stimulated the release of taurine. NMDA-mediated taurine release was inhibited by either APV, Ketamine or the NO synthase inhibitor L-NAME. Lubeluzole had no effect. Under the hypotonic conditions only lubeluzole was effective. These data confirm in vivo that the NMDA-induced taurine release is mediated via the NO cascade. By contrast, the release after a hypotonic stimulus is not related to the NO cascade. Instead, Na(+)- and/or Ca(2+)-mediated events might have been attenuated by lubeluzole.


Subject(s)
Taurine/metabolism , Telencephalon/metabolism , Animals , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Male , Microdialysis , N-Methylaspartate/antagonists & inhibitors , N-Methylaspartate/pharmacology , Nitric Oxide/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Rats , Rats, Wistar , Telencephalon/drug effects
6.
Amino Acids ; 19(3-4): 571-83, 2000.
Article in English | MEDLINE | ID: mdl-11140360

ABSTRACT

Taurine and glutamate were monitored by microdialysis technique during various cerebral insults: a. Application of K+ triggered a cortical spreading depression (CSD). Taurine and glutamate increased concomitantly but recovery of glutamate was faster than that of taurine. b. Application of NMDA induced also CSD but only taurine increased. c. Induction of an infarct triggered repetitive CSDs. Taurine increased rapidly whereas glutamate rose slowly starting with some delay. d. After induction of ischemia, taurine and glutamate increased after onset of depolarisation. The increase of glutamate occurred late after a small, transient increase in parallel with the depolarisation. These data suggest a close functional relationship between the changes of both amino acids. Therefore, they should be monitored together especially in clinical settings: during excitation, only taurine will increase; during overexcitation, taurine will also increase but to a higher maximum followed by a moderate rise of glutamate; after energy failure, taurine will accumulate to its highest level followed by a continuous rise of glutamate.


Subject(s)
Brain Ischemia/metabolism , Cerebral Infarction/metabolism , Glutamic Acid/metabolism , Taurine/metabolism , Animals , Brain Ischemia/physiopathology , Cerebral Infarction/physiopathology , Cortical Spreading Depression , Extracellular Space/metabolism , Male , Microdialysis , Rats , Rats, Wistar
7.
Eur J Pharmacol ; 338(3): 243-51, 1997 Nov 12.
Article in English | MEDLINE | ID: mdl-9424018

ABSTRACT

A microdialysis probe was positioned inside the peri-infarct zone of a photochemically induced neocortical infarct in rats. Extracellular glutamate rose within 20 min after the start of infarct induction and continued to increase during the 5 h observation period to 5.5-fold the pre-infarct baseline value of 0.8 +/- 0.4 micromol/l. Glutamine increased only 1.4-fold. Changes in peri-infarct glutamate were preceded by steep rises in taurine (a 3.9-fold increase from the baseline value of 2.8 +/- 0.7 micromol/l), which coincided with spreading depressions during infarct induction. Post-treatment with lubeluzole ((S)-4-(2-benzothiazolylmethylamino)-alpha-[(3,4-difluoro-phenoxy) methyl]-1-piperidineethanol, 1.25 mg/kg i.v.), a new cerebroprotective drug, blocked the peri-infarct increases of glutamate and taurine, whereas the R-enantiomer was ineffective. Since lubeluzole has previously been shown to stereospecifically decrease glutamate-activated nitric oxide (NO) toxicity in vitro, the present in vivo stereospecific effect of lubeluzole may be related to modulation of the cascade of NO toxicity, thus preventing NO toxicity-mediated increases in extracellular glutamate. Blockade of the peri-infarct taurine response suggests that lubeluzole also may have reduced cellular osmotic stress in the peri-infarct zone.


Subject(s)
Cerebral Infarction/drug therapy , Cortical Spreading Depression/drug effects , Glutamic Acid/metabolism , Neocortex/metabolism , Neuroprotective Agents/pharmacology , Piperidines/pharmacology , Taurine/metabolism , Thiazoles/pharmacology , Animals , Blood Pressure/drug effects , Cerebral Infarction/metabolism , Cortical Spreading Depression/physiology , Glutamine/metabolism , Heart Rate/drug effects , Male , Neocortex/drug effects , Rats , Rats, Wistar
8.
J Clin Pharmacol ; 33(4): 330-4, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8473547

ABSTRACT

The effects of concurrent administration of either cimetidine 800 mg once daily or ranitidine 300 mg once daily on the single-dose pharmacokinetics of ritanserin 10 mg were investigated in an open, randomized three-way cross-over, controlled investigation in 9 healthy volunteers. Concurrent administration of cimetidine had no significant effect on the area under the plasma concentration-time curve of ritanserin compared with control experiments. The maximum plasma concentration of ritanserin was decreased significantly (105.0 +/- 9.2 versus 125.0 +/- 13.8 ng/mL; P = .0039), whereas time to reach maximal concentration (tmax) of ritanserin was only slightly but not significantly increased, if the subjects were pretreated with cimetidine. After concurrent ingestion of ranitidine, only a trend to a decrease in the maximum plasma concentration of ritanserin was observed. Time to achieve the maximum plasma concentration, terminal half-life of elimination, and the total area under the plasma concentration-time curve of ritanserin were not altered in comparison with control experiments. The results of the study show that concurrent treatment with cimetidine 800 mg once daily or ranitidine 300 mg once daily has no apparent effect on the systemically available amount of ritanserin after a single oral dose of 10 mg. Both H2-antagonists cause a significant (cimetidine) or borderline significant (ranitidine) decrease of the maximum plasma concentration of ritanserin and a slight but not significant increase in tmax (cimetidine). These effects are of minor clinical importance and seem most likely be due to a decrease of the rate of absorption of ritanserin during concurrent administration of cimetidine/ranitidine.


Subject(s)
Cimetidine/pharmacology , Ranitidine/pharmacology , Ritanserin/pharmacokinetics , Adult , Cimetidine/administration & dosage , Drug Administration Schedule , Humans , Male , Ranitidine/administration & dosage
9.
Arzneimittelforschung ; 42(9): 1069-72, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1359893

ABSTRACT

A sensitive and reproducible high performance liquid chromatographic method was developed for the determination of pipamperone (1'-[4-(4-fluorophenyl)-4-oxobutyl]-[1,4'-bipiperidine]-4'- carboxamide, Dipiperon, CAS 1893-33-0) in plasma samples. Pipamperone and its internal standard (piritramide or 1'-(3-cyano-3,3-diphenylpropyl)-[1,4'-bipiperidine]-4'-carbo xamide) were extracted from alkalinized plasma by liquid-liquid extraction and analysed on a reversed-phase (C18) column. In order to reduce analysis time, a gradient elution technique was applied. Chromatographic peaks were quantified by UV detection at two wavelengths. The method has a detection limit of 2 ng/ml, it proved to have good accuracy and precision, and was linear in the range of 2 to 400 ng/ml. The assay was extensively applied to study the pharmacokinetics in man after oral administration of the drug.


Subject(s)
Antipsychotic Agents/blood , Ascorbic Acid/analogs & derivatives , Butyrophenones/blood , Free Radical Scavengers , Vitamin E/analogs & derivatives , Antipsychotic Agents/pharmacokinetics , Ascorbic Acid/pharmacology , Butyrophenones/pharmacokinetics , Chromatography, High Pressure Liquid , Humans , Quality Control , Solutions , Vitamin E/pharmacology
10.
Ann N Y Acad Sci ; 646: 322-33, 1991 Dec 27.
Article in English | MEDLINE | ID: mdl-1809200

ABSTRACT

The development of an integrated system for the continuous, automated production of pure cell culture derived proteins is discussed. The system comprises a cell culture subunit for the continuous culture of mammalian cells and a purification subunit linked on-line to the cell culture subunit. The cells are compartmentalized and continuously perfused with culture medium. The cell culture medium leaving the bioreactor is perfused through a sterile immunoaffinity column that instantaneously removes the product from the culture fluid. This results in improved product quality because the product is quickly removed from the cell culture, thus minimizing contact with degradative enzymes. The culture medium, stripped from the secreted product, is recirculated into the bioreactor. The system allows simple, automated, and economical production of purified proteins with higher quality than that possible with current production methods. The integration also allows on-line, real-time process monitoring, thus simplifying process development and allowing more consistent production of biologics.


Subject(s)
Biotechnology , Cells, Cultured , Recombinant Proteins/isolation & purification , Animals , Antibodies, Monoclonal/isolation & purification , Automation , Chromatography, Affinity , Culture Media/chemistry , Electrophoresis, Polyacrylamide Gel , Glucose/metabolism , Hybridomas , Lactates/metabolism , Mice
15.
Z Kardiol ; 78 Suppl 5: 108-11, 1989.
Article in German | MEDLINE | ID: mdl-2534340

ABSTRACT

Following Skelton's procedure with unilateral adrenonephrectomy, contralateral adrenal enucleation and application of 1% NaCl with drinking fluid, normal rats develop hypertension and generalized severe arteriosclerosis within 7 weeks, experimental group I. Thereby the mean systolic blood pressure increased from 108 +/- 10 to 223 +/- 12 mm Hg, and 90 arteriosclerotic blood vessels could be counted in 100 histological sections (10 from each animal) of the hearts. Following Skelton's procedure and admixture of flunarizine with the food (40 mg flunarizine per kg for 8 weeks, started 1 week before the operation; mean plasma flunarizine value: 336 +/- 136 ng/ml at the end of the experiment), experimental group II, all rats developed hypertension too, whereby the mean systolic blood pressure increased from 109 +/- 10 to 214 +/- 16 mm Hg, but in contrast to experimental group I, only one artery with sclerosis could be observed in 100 comparable histological sections of the hearts. The untreated control rats, experimental group III, remained normotensive, and no arteriosclerotic blood vessels could be observed. The findings presented show that the calcium-antagonist flunarizine with the dosage used does not reduce hypertension, but almost completely suppresses hypertension-induced arteriosclerosis of the myocardial blood vessels without lowering the high blood pressure.


Subject(s)
Blood Pressure/drug effects , Coronary Artery Disease/pathology , Flunarizine/pharmacology , Hypertension/pathology , Animals , Cardiomegaly/pathology , Coronary Vessels/pathology , Endothelium, Vascular/pathology , Fibrin/metabolism , Male , Muscle, Smooth, Vascular/pathology , Organ Size/drug effects , Rats , Rats, Inbred Strains
16.
J Chromatogr ; 487(1): 99-105, 1989 Jan 27.
Article in English | MEDLINE | ID: mdl-2715279

ABSTRACT

The analytical method described here provides the appropriate sensitivity and selectivity for the determination of unlabelled hydroxypropyl-beta-cyclodextrin as a parenteral carrier in pharmaceutical formulations. The method may also be used in clinical trials evaluating the fate and pharmacokinetic profile of this compound, which was isolated from the biological matrix by solid-phase extraction with Bond Elut C18 cartridges. The lack of uniformity of the product was circumvented by the use of a size-exclusion chromatographic column. An indirect colorimetric complexation method was used for detection. The detection limit was 0.1 micrograms per 2 ml of biological fluid and the extraction recovery was sufficient (78%).


Subject(s)
Cyclodextrins/pharmacokinetics , Dextrins/pharmacokinetics , Starch/pharmacokinetics , beta-Cyclodextrins , 2-Hydroxypropyl-beta-cyclodextrin , Animals , Chromatography, Liquid , Cyclodextrins/blood , Cyclodextrins/urine , Male , Rats , Rats, Inbred Strains
18.
Z Rechtsmed ; 94(4): 273-87, 1985.
Article in German | MEDLINE | ID: mdl-4050135

ABSTRACT

The chemical composition of subcutaneous fats was analyzed in a corpse that had died from drowning. The skin of the cadaver examined postmortem showed different stages of adipocere. Samples from these regions were chemically compared with the fatty tissue of a person who had died recently. HPLC, GC, GC-MS, NMR (1H- and 13C-NMR), TLC and titrimetrical methods were used to evaluate the degree of decomposition. The fatty acid pattern of the triglycerides (TG) and the free fatty acids (FFA) obtained by TLC separation was also investigated. Some discrepancy was observed between the autopsy findings and the results of the chemical analysis. It is suggested that the autopsy should be supplemented by chemical analysis in order to describe the state of adipocere correctly.


Subject(s)
Forensic Medicine , Lipids/analysis , Postmortem Changes , Adipose Tissue/analysis , Chromatography, Gas , Chromatography, High Pressure Liquid , Drowning/pathology , Gas Chromatography-Mass Spectrometry , Humans , Magnetic Resonance Spectroscopy
19.
Z Rechtsmed ; 92(2): 101-7, 1984.
Article in German | MEDLINE | ID: mdl-6372310

ABSTRACT

Randomly taken postmortem urine samples (170) were analyzed by the Emit-dau system for their barbiturate and benzodiazepine content. Of the samples, 23% and 25% were found positive for barbiturate and benzodiazepine, respectively. The percentages of the positive samples were reduced by a heating process to 9% and 11%, respectively. TLC and Emit-st were used for reference procedures. The relative high percentage (above 30%) of the urine samples analyzed exhibited elevated lysozyme activity and protein value. It was found that the disturbing proteins in the Emit-dau system contained not only endogene lysozyme but other thermolabile fractions with higher molecular weight.


Subject(s)
Barbiturates/analysis , Benzodiazepines/analysis , Cadaver , Forensic Medicine , Urine/analysis , Humans , Immunoenzyme Techniques , Muramidase/urine , Proteinuria/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL